These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 32778549)

  • 1. Pharmacodynamics of the Novel Metallo-β-Lactamase Inhibitor ANT2681 in Combination with Meropenem for the Treatment of Infections Caused by NDM-Producing
    Das S; Johnson A; McEntee L; Farrington N; Kirby A; Unsworth J; Jimenez-Valverde A; Kolamunnage-Dona R; Bousquet J; Alibaud L; Sable C; Zalacain M; Everett M; Hope W
    Antimicrob Agents Chemother; 2020 Oct; 64(11):. PubMed ID: 32778549
    [No Abstract]   [Full Text] [Related]  

  • 2. ANT2681: SAR Studies Leading to the Identification of a Metallo-β-lactamase Inhibitor with Potential for Clinical Use in Combination with Meropenem for the Treatment of Infections Caused by NDM-Producing
    Davies DT; Leiris S; Sprynski N; Castandet J; Lozano C; Bousquet J; Zalacain M; Vasa S; Dasari PK; Pattipati R; Vempala N; Gujjewar S; Godi S; Jallala R; Sathyap RR; Darshanoju NA; Ravu VR; Juventhala RR; Pottabathini N; Sharma S; Pothukanuri S; Holden K; Warn P; Marcoccia F; Benvenuti M; Pozzi C; Mangani S; Docquier JD; Lemonnier M; Everett M
    ACS Infect Dis; 2020 Sep; 6(9):2419-2430. PubMed ID: 32786279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Specific Metallo-β-Lactamase Inhibitor ANT2681 Restores Meropenem Activity to Clinically Effective Levels against NDM-Positive
    Zalacain M; Lozano C; Llanos A; Sprynski N; Valmont T; De Piano C; Davies D; Leiris S; Sable C; Ledoux A; Morrissey I; Lemonnier M; Everett M
    Antimicrob Agents Chemother; 2021 May; 65(6):. PubMed ID: 33820763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,4,7-Triazacyclononane Restores the Activity of β-Lactam Antibiotics against Metallo-β-Lactamase-Producing
    Somboro AM; Amoako DG; Osei Sekyere J; Kumalo HM; Khan R; Bester LA; Essack SY
    Appl Environ Microbiol; 2019 Feb; 85(3):. PubMed ID: 30478231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfamoyl Heteroarylcarboxylic Acids as Promising Metallo-β-Lactamase Inhibitors for Controlling Bacterial Carbapenem Resistance.
    Wachino JI; Jin W; Kimura K; Kurosaki H; Sato A; Arakawa Y
    mBio; 2020 Mar; 11(2):. PubMed ID: 32184250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of a Novel Metallo-β-Lactamase Inhibitor That Potentiates Meropenem Activity against Carbapenem-Resistant Enterobacteriaceae.
    Everett M; Sprynski N; Coelho A; Castandet J; Bayet M; Bougnon J; Lozano C; Davies DT; Leiris S; Zalacain M; Morrissey I; Magnet S; Holden K; Warn P; De Luca F; Docquier JD; Lemonnier M
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29530861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics/pharmacodynamics of a β-lactam and β-lactamase inhibitor combination: a novel approach for aztreonam/avibactam.
    Singh R; Kim A; Tanudra MA; Harris JJ; McLaughlin RE; Patey S; O'Donnell JP; Bradford PA; Eakin AE
    J Antimicrob Chemother; 2015 Sep; 70(9):2618-26. PubMed ID: 26024868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics/Pharmacodynamics of Vaborbactam, a Novel Beta-Lactamase Inhibitor, in Combination with Meropenem.
    Griffith DC; Sabet M; Tarazi Z; Lomovskaya O; Dudley MN
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30397063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. H
    Chen F; Bai M; Liu W; Kong H; Zhang T; Yao H; Zhang E; Du J; Qin S
    Eur J Med Chem; 2021 Nov; 224():113702. PubMed ID: 34303873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific NDM-1 Inhibitor of Isoliquiritin Enhances the Activity of Meropenem against NDM-1-positive
    Wang Y; Sun X; Kong F; Xia L; Deng X; Wang D; Wang J
    Int J Environ Res Public Health; 2020 Mar; 17(6):. PubMed ID: 32213926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Human-Simulated Epithelial Lining Fluid Exposure of Meropenem-Nacubactam Combination against Class A Serine β-Lactamase-Producing
    Asempa TE; Motos A; Abdelraouf K; Bissantz C; Zampaloni C; Nicolau DP
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and characterization of New Delhi metallo-β-lactamase-1 inhibitor peptides that potentiate meropenem-dependent killing of carbapenemase-producing Enterobacteriaceae.
    Kazi MI; Perry BW; Card DC; Schargel RD; Ali HB; Obuekwe VC; Sapkota M; Kang KN; Pellegrino MW; Greenberg DE; Castoe TA; Boll JM
    J Antimicrob Chemother; 2020 Oct; 75(10):2843-2851. PubMed ID: 32591801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restoring carbapenem efficacy: a novel carbapenem companion targeting metallo-β-lactamases in carbapenem-resistant Enterobacterales.
    Ooi N; Lee VE; Chalam-Judge N; Newman R; Wilkinson AJ; Cooper IR; Orr D; Lee S; Savage VJ
    J Antimicrob Chemother; 2021 Jan; 76(2):460-466. PubMed ID: 33152764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SAR Studies Leading to the Identification of a Novel Series of Metallo-β-lactamase Inhibitors for the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections That Display Efficacy in an Animal Infection Model.
    Leiris S; Coelho A; Castandet J; Bayet M; Lozano C; Bougnon J; Bousquet J; Everett M; Lemonnier M; Sprynski N; Zalacain M; Pallin TD; Cramp MC; Jennings N; Raphy G; Jones MW; Pattipati R; Shankar B; Sivasubrahmanyam R; Soodhagani AK; Juventhala RR; Pottabathini N; Pothukanuri S; Benvenuti M; Pozzi C; Mangani S; De Luca F; Cerboni G; Docquier JD; Davies DT
    ACS Infect Dis; 2019 Jan; 5(1):131-140. PubMed ID: 30427656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and pharmacodynamics of the novel monobactam LYS228 in a neutropenic murine thigh model of infection.
    Growcott EJ; Cariaga TA; Morris L; Zang X; Lopez S; Ansaldi DA; Gold J; Gamboa L; Roth T; Simmons RL; Osborne CS
    J Antimicrob Chemother; 2019 Jan; 74(1):108-116. PubMed ID: 30325447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dithiocarbamates: Efficient metallo-β-lactamase inhibitors with good antibacterial activity when combined with meropenem.
    Wang MM; Chu WC; Yang Y; Yang QQ; Qin SS; Zhang E
    Bioorg Med Chem Lett; 2018 Nov; 28(21):3436-3440. PubMed ID: 30262427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vitro and In Vivo Development of a β-Lactam-Metallo-β-Lactamase Inhibitor: Targeting Carbapenem-Resistant
    Peters BK; Reddy N; Shungube M; Girdhari L; Baijnath S; Mdanda S; Chetty L; Ntombela T; Arumugam T; Bester LA; Singh SD; Chuturgoon A; Arvidsson PI; Maguire GEM; Kruger HG; Naicker T; Govender T
    ACS Infect Dis; 2023 Mar; 9(3):486-496. PubMed ID: 36786013
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Abdelraouf K; Stainton SM; Nicolau DP
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31061165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamic Attainment of the Synergism of Meropenem and Fosfomycin Combination against Pseudomonas aeruginosa Producing Metallo-β-Lactamase.
    Albiero J; Mazucheli J; Barros JPDR; Szczerepa MMDA; Nishiyama SAB; Carrara-Marroni FE; Sy S; Fidler M; Sy SKB; Tognim MCB
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30910903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics-Pharmacodynamics of a Novel β-Lactamase Inhibitor, CB-618, in Combination with Meropenem in an In Vitro Infection Model.
    VanScoy BD; Trang M; McCauley J; Conde H; Bhavnani SM; Friedrich LV; Alexander DC; Ambrose PG
    Antimicrob Agents Chemother; 2016 Jul; 60(7):3891-6. PubMed ID: 27001820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.